Hurst Photo / Shutterstock.com
Natco Pharma, an India-based drugs company, announced today that it has received final approval from the US Food and Drug Administration to produce a generic version of Tamiflu (oseltamivir phosphate).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Natco Pharma, FDA, ANDA, Tamiflu, oseltamivir phosphate, patent